Sub-acute toxicity of licorice–sargassum extract in Sprague-Dawley rats

Xinyue Jing,Xian Meng,Zhenhui Wu,Yongfang Ding,Yunru Peng,Mingqing Shen,Qing Wang
DOI: https://doi.org/10.1097/cm9.0000000000001716
IF: 6.133
2021-09-21
Chinese Medical Journal
Abstract:To the Editor: The "eighteen antagonistic medicaments," an indispensable component of Oriental Pharmacology, states that sargassum and licorice should not be administered simultaneously.[1] Researchers have reported that co-administration of licorice and sargassum exerted toxic effects on the heart, liver, and kidney of rats.[2,3] However, the classic recipe "Hai-Zao-Yu-Hu-Tang," (containing licorice and sargassum) is currently used, though the safety profile of this medication has not been clearly defined. Therefore, a toxicological study of the combination of sargassum and licorice is necessary to determine its safety profile. In this study, a sub-acute toxicity test was used to evaluate toxicity. The main active components of licorice were liquirtin, isoliquiritin, liquiritigenin, isoliquiritigenin, and glycyrrhizic acid (GL). GL may be converted into glycyrrhetinic acid (GA) in vivo. Research has shown that the plasma concentrations of GA in rats are elevated after the oral administration of laminaria-licorice extract vs. licorice extract alone.[4] In this study, we developed an ultra-performance liquid chromatography coupled with triple-quadrupole mass spectrometry (UPLC-TQ/MS) method for the simultaneous determination of the six main components of licorice in rat plasma.
medicine, general & internal
What problem does this paper attempt to address?